Help Print this page 

Document C2014/396/07

Title and reference
Prior notification of a concentration (Case M.7337 — IMS Health/Cegedim Business) Text with EEA relevance

OJ C 396, 11.11.2014, p. 30–30 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Languages, formats and link to OJ
BG ES CS DA DE ET EL EN FR GA HR IT LV LT HU MT NL PL PT RO SK SL FI SV
HTML html BG html ES html CS html DA html DE html ET html EL html EN html FR html HR html IT html LV html LT html HU html MT html NL html PL html PT html RO html SK html SL html FI html SV
PDF pdf BG pdf ES pdf CS pdf DA pdf DE pdf ET pdf EL pdf EN pdf FR pdf HR pdf IT pdf LV pdf LT pdf HU pdf MT pdf NL pdf PL pdf PT pdf RO pdf SK pdf SL pdf FI pdf SV
Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal Display Official Journal
 To see if this document has been published in an e-OJ with legal value, click on the icon above (For OJs published before 1st July 2013, only the paper version has legal value).
Multilingual display
Text

11.11.2014   

EN

Official Journal of the European Union

C 396/30


Prior notification of a concentration

(Case M.7337 — IMS Health/Cegedim Business)

(Text with EEA relevance)

2014/C 396/07

1.

On 4 November 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking IMS Health (United States of America) acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of part of the businesses of Cegedim SA (France) (‘the Cegedim Business’) by way of purchase of assets.

2.

The business activities of the undertakings concerned are:

—   for IMS Health: market research information, consulting and technology services relating to the healthcare, biotech, life sciences and pharmaceutical industries,

—   Cegedim Business: market research information, consulting and technology services relating to the healthcare, biotech, life sciences and pharmaceutical industries.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7337 — IMS Health/Cegedim Business:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË


(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).


Top